EUVIMEDEUVIMED entdecken
Crossref

Semaglutide after metabolic and bariatric surgery: advancing treatment for suboptimal weight loss and weight regain

Audrey White, Darren K. McGuire

Metabolism and Target Organ Damage · 06.11.2026 · 6 (4)

DOI: 10.20517/mtod.2026.194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 06.11.2026. Verfasst von Audrey White und 1 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

White, A., & McGuire, D. K. (2026). Semaglutide after metabolic and bariatric surgery: advancing treatment for suboptimal weight loss and weight regain. Metabolism and Target Organ Damage, 6(4). https://doi.org/10.20517/mtod.2026.194

Vancouver

White A, McGuire DK. Semaglutide after metabolic and bariatric surgery: advancing treatment for suboptimal weight loss and weight regain. Metabolism and Target Organ Damage. 2026;6(4). doi:10.20517/mtod.2026.194

BibTeX
@article{White2026,
  author = {White, Audrey and McGuire, Darren K.},
  title = {Semaglutide after metabolic and bariatric surgery: advancing treatment for suboptimal weight loss and weight regain},
  journal = {Metabolism and Target Organ Damage},
  year = {2026},
  volume = {6},
  number = {4},
  doi = {10.20517/mtod.2026.194}
}
Kostenlos starten →